false
OasisLMS
Catalog
Diabetes Strategies for Endocrinologists
Personalized Pharmacotherapy for Patients with T2D
Personalized Pharmacotherapy for Patients with T2D
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video summarizes a session on personalized treatment for patients with diabetes. The two speakers discuss various cases and the best therapeutic options for each patient. In the first case, the patient is a 67-year-old Latina female with type 2 diabetes, treated for hypertension and dyslipidemia. She is already on multiple medications, including metformin, and is being told to add insulin to her regimen. The speakers discuss different treatment options, including increasing the dose of metformin, adding different types of insulin, or adding other oral medications like SGLT2 inhibitors or GLP-1 receptor agonists. They discuss the potential benefits and risks of each option and recommend individualized treatment based on the patient's specific needs and risk factors. <br /><br />In the second case, the patient is a 73-year-old male with new-onset type 2 diabetes and heart failure. The speakers discuss the use of SGLT2 inhibitors in patients with heart failure and the potential benefits on both glycemic control and heart failure outcomes. They also mention the use of GLP-1 receptor agonists for weight loss in patients with obesity and type 2 diabetes. <br /><br />Overall, the speakers emphasize the importance of personalized treatment for patients with diabetes, taking into account their individual characteristics, comorbidities, and treatment goals. They discuss the role of different medications and recommend individualized treatment plans for each patient. <br /><br />No credits were granted in the video.
Keywords
personalized treatment
diabetes
therapeutic options
type 2 diabetes
metformin
insulin
SGLT2 inhibitors
GLP-1 receptor agonists
heart failure
×
Please select your language
1
English